KRBPQ (Kiromic BioPharma) FCF Yield %: 0.00 (As of Jul. 18, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Kiromic BioPharma FCF Yield %?

Kiromic BioPharma KRBPQ FCF Yield % is 0.00 as of Jul. 18, 2026.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Kiromic BioPharma's Trailing 12-Month Free Cash Flow is $-19.82 Mil, and Market Cap is $0.00 Mil. Therefore, Kiromic BioPharma's FCF Yield % for today is 0.00%.

The historical rank and industry rank for Kiromic BioPharma's FCF Yield % or its related term are showing as below:


KRBPQ's FCF Yield % is not ranked *
in the Biotechnology industry.
Industry Median: -9.75
* Ranked among companies with meaningful FCF Yield % only.

Kiromic BioPharma's FCF Margin % for the quarter that ended in Dec. 2024 was 0.00%.

Kiromic BioPharma FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Kiromic BioPharma FCF Yield % Related Terms

Kiromic BioPharma FCF Yield % Historical Data

* Premium members only.

The historical data trend for Kiromic BioPharma's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kiromic BioPharma FCF Yield % Chart

Kiromic BioPharma Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
FCF Yield %
Get a 7-Day Free Trial -12.23 -93.80 -814.93 -1,958.23 -1,436.83

Kiromic BioPharma Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,976.87 -623.30 -980.52 -397.34 -1,065.74

KRBPQ vs VRTX, REGN, ALNY: FCF Yield % Comparison

For the Biotechnology subindustry, Kiromic BioPharma's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kiromic BioPharma FCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kiromic BioPharma's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Kiromic BioPharma's FCF Yield % falls into.


Kiromic BioPharma FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Kiromic BioPharma's FCF Yield % for the fiscal year that ended in Dec. 2024 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-19.824 / 1.3797
=-1,436.83%

Kiromic BioPharma's annualized FCF Yield % for the quarter that ended in Dec. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-3.676 * 4 / 1.3797
=-1,065.74%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of 0.00 mean?
Kiromic BioPharma (KRBPQ) has a FCF Yield % of 0.00 as of Jul. 18, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Kiromic BioPharma and its competitors.
Is Kiromic BioPharma's FCF Yield % too high?
Kiromic BioPharma's current FCF Yield % is 0.00.
How does Kiromic BioPharma's FCF Yield % compare to VRTX and REGN?
Kiromic BioPharma's FCF Yield % of 0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Kiromic BioPharma and its competitors. Kiromic BioPharma's current FCF Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kiromic BioPharma stock overvalued right now?
Kiromic BioPharma (KRBPQ) has a current FCF Yield % of 0.00. The current FCF Yield % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Kiromic BioPharma (KRBPQ), the current FCF Yield % is 0.00 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kiromic BioPharma Business Description

Address 7707 Fannin Street, Suite 200, Houston, TX, USA, 77054
Kiromic BioPharma Inc is a biotechnology company. It is an artificial intelligence (AI) driven, end-to-end allogeneic cell therapy company, currently developing the multi-indication allogeneic T cell therapy that exploits the natural potency of the Gamma Delta T cell (GDT) to target solid tumors. The company is a gene-editing which utilizes artificial intelligence and a proprietary neural network platform with a therapeutic focus on immuno-oncology.